Literature DB >> 2124095

Changes in circulating hormone levels after ovarian wedge resection in patients with polycystic ovary syndrome.

A Szilágyi1, W Rossmanith, T Csermely, I Csaba.   

Abstract

Serum gonadotropin, prolactin, estradiol, sex hormone binding globulin (SHBG) and androgen levels were measured before, 5 days and 6 weeks following ovarian wedge resection in 9 patients with polycystic ovary syndrome. Elevated levels of LH, androstenedione, testosterone and dehydroepiandrosterone-sulphate (DHEA-S) were found before surgery. There was a marked decrease in androstenedione and DHEA-S levels 5 days following wedge resection, but a rebound effect could be observed 6 weeks later. Serum gonadotropin, prolactin, testosterone and SHBG concentrations were practically unaffected by surgery. At 6-12 months follow up patients showed regular, mainly ovulatory cycles, but pregnancy occurred only in two cases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2124095     DOI: 10.1007/bf02389587

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  12 in total

Review 1.  STEROID SECRETIONS OF THE NORMAL AND POLYCYSTIC OVARY.

Authors:  V B MAHESH; R B GREENBLATT
Journal:  Recent Prog Horm Res       Date:  1964

Review 2.  Polycystic ovaries and polycystic ovary syndrome.

Authors:  H S Jacobs
Journal:  Gynecol Endocrinol       Date:  1987-03       Impact factor: 2.260

Review 3.  The polycystic ovary syndrome.

Authors:  S S Yen
Journal:  Clin Endocrinol (Oxf)       Date:  1980-02       Impact factor: 3.478

Review 4.  Polycystic ovarian disease.

Authors:  J W Goldzieher
Journal:  Fertil Steril       Date:  1981-04       Impact factor: 7.329

5.  Fertility following bilateral ovarian wedge resection: a critical analysis of 90 consecutive cases of the polycystic ovary syndrome.

Authors:  E Y Adashi; J A Rock; D Guzick; A C Wentz; G S Jones; H W Jones
Journal:  Fertil Steril       Date:  1981-09       Impact factor: 7.329

6.  Endocrine effects of ovarian electrocautery in patients with polycystic ovarian disease.

Authors:  H Gjønnaess; N Norman
Journal:  Br J Obstet Gynaecol       Date:  1987-08

7.  Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.

Authors:  R Rebar; H L Judd; S S Yen; J Rakoff; G Vandenberg; F Naftolin
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

8.  The effects of ovarian wedge resection on circulating gonadotropin and ovarian steroid levels in patients with polycystic ovary syndrome.

Authors:  H L Judd; L A Rigg; D C Anderson; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1976-08       Impact factor: 5.958

9.  Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.

Authors:  A E Calogero; M Macchi; V Montanini; A Mongioi; G Maugeri; E Vicari; F Coniglione; C Sipione; R D'Agata
Journal:  J Clin Endocrinol Metab       Date:  1987-05       Impact factor: 5.958

10.  STEROID HORMONE FORMATION IN THE HUMAN OVARY. I. IDENTIFICATION OF STEROIDS FORMED IN VITRO FROM ACETATE-1-14C IN THE CORPUS LUTEUM.

Authors:  J HAMMERSTEIN; B F RICE; K SAVARD
Journal:  J Clin Endocrinol Metab       Date:  1964-07       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.